Abstract:Artemisinin is a sesquiterpene lactone compound containing a peroxy bridge structure, extracted from Compositae Artemisia annua L. in 1971.Discovered by Chinese researchers, artemisinin and its derivatives are currently the most effective drugs in the world for the treatment of chloroquine-resistant Plasmodium falciparumstrains and cerebral malaria.As first-line antimalarial medicines, artemisinin and its derivatives have saved millions of lives, and artemisinin has been reputed as "the best hope for malaria treatment" by World Health Organization.At Nobel Prize Award Ceremony in 2015, Tu Youyou, a natural product medicinal chemist at the China Academy of Chinese Medical Sciences who made significant contribution to the discovery of artemisinin as an antimalarial drug, delivered a speech entitled "Artemisinin-A gift from traditional Chinese medicine to the world".Tu said: "From research experience gained from artemisinin discovery, we learnt strengths of both Chinese and Western medicines.There is great potential and future advances if these strengths can be fully integrated.We have a substantial amount of natural resource from which our fellow medical researchers can develop novel medicines".Doubtless the discovery of artemisinin represents a banner in the history of Chinese pharmaceutical industry, which is of immense significance both to enlighten the currently much modernized drug discovery world and to encourage young generations of scientists working with the traditional Chinese medicines.In order to understand the antimalarial mechanism of artemisinin analogues, we firstly discussed on quantitative structureactivity relationship, structure-based physico-chemical properties, and molecular docking generated putative "bioactive" conformations of artemisinin analogues.In addition to the outstanding antimalarial activity, artemisinin and its derivatives also show significant immunosuppressive effects both in vitro and in vivo.We then summarized some typical artemisinin analogues that exhibit promising therapeutic effects on multiple autoimmune diseases, by suppressing the differentiation and expansion of pathologic T helper cells and accumulation of plasma cells, etc.The unusual endoperoxide and multiple cyclic structure of artemisinin has also been extensively explored to develop analogues with cytotoxic anticancer effects.Unfortunately, most of these artemisinin analogues failed to show tumor growth inhibition in vivo.To overcome this limitation, we finally reviewed some recent progresses to develop molecularly targeted anticancer therapies derived from artemisinin, by combining the typical skeleton of artemisinin or its fragmented intermediates with a molecularly targeted drug bullet.Among several tried approaches, the incorporation of a Smo antagonistic structural motif into the structure of artemisinin led to highly potent Smo-targeting antagonists.The recognition by the Nobel Prize does not mean that the study of artemisinin is over; instead, this great honor will inspire scientists around the world to move on to discover more therapeutic effects of artemisinin compounds, and to explore other potential gifts from Traditional Chinese Medicine.

Network Analysis, and Experimental Validation to Uncover the Mechanism of the Four Compounds in Artemisia Annua (qing Hao) Antimalarial

Investigation of the component in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin via regulation of its metabolism.

Research Progress on Pharmacological Activities of Artemisinin and Its Derivatives

[Research Advances of Biosynthesis, in Vivo Analysis and Pharmacokinetics of Chemical Constituents in Artemisiae Annuae Herba].

Targeted screening of the synergistic components in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin based on a "top down" PD-PK approach

Exploring the pharmacological mechanism of Artemisia annua herba based on network pharmacology

Structure-activity Relationships of the Antimalarial Agent Artemisinin and the Research Progress on the Artemisinin Analogues with Novel Pharmacological Actions

New Sesquiterpene and Polymethoxy-Flavonoids from Artemisia Annua L

Phytochemical analysis and geographic assessment of flavonoids, coumarins and sesquiterpenes in Artemisia annua L. based on HPLC-DAD quantification and LC-ESI-QTOF-MS/MS confirmation

Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study

Interaction of Antimalarial Components Combination from Artemisia annua L. with Bovine Serum Albumin

Advances in the research on the targets of anti-malaria actions of artemisinin

Rapid Profiling of the Marker Components in Artemisia Annua L. and Their Metabolites in Rats Using an Improved Liquid Chromatography-tandem Highresolution Mass Spectrometry-based Technology.

A Pharmacoinformatics Analysis of Artemisinin Targets and De Novo Design of Hits for Treating Ulcerative Colitis

[Anti-Inflammatory Material Basis and Mechanism of Artemisia Stolonifera Based on UPLC-Q-TOF-MS Combined with Network Pharmacology and Molecular Docking].

Artemisinin Rewires the Protein Interaction Network in Cancer Cells: Network Analysis, Pathway Identification, and Target Prediction

Progress on Pharmacological Action of Artemisia Annua

Multitarget Mechanism of Artemisia Plants to Fight Respiratory Tract Infections Based on Network Pharmacology and Molecular Docking

Mechanism of Artemisia annua L. in the treatment of acute myocardial infarction: network pharmacology, molecular docking and in vivo validation

Biological Activities of Artemisinin Derivatives Beyond Malaria.

Discovery, mechanisms of action and combination therapy of artemisinin.